Immunohistochemistry Germ Cell Tumor Panel Test
Comprehensive Diagnostic Solution for Germ Cell Tumors
The Immunohistochemistry Germ Cell Tumor Panel Test represents a cutting-edge diagnostic approach in cancer pathology, specifically designed to identify and characterize germ cell tumors with exceptional precision. This advanced testing methodology utilizes immunohistochemical staining techniques to detect specific protein markers that are characteristic of various germ cell malignancies, providing oncologists and pathologists with critical information for accurate diagnosis and treatment planning.
What This Test Measures and Detects
Our comprehensive panel analyzes seven crucial biomarkers that play essential roles in germ cell tumor identification and classification:
- CD30: Identifies embryonal carcinoma components
- CD117: Detects seminoma and dysgerminoma markers
- Glypican3: Specific for yolk sac tumor components
- HCG: Human chorionic gonadotropin for choriocarcinoma detection
- Inhibin: Marks sex cord-stromal tumors and some germ cell elements
- PLAP: Placental alkaline phosphatase for seminoma identification
- SALL4: Broad germ cell tumor marker for various subtypes
Who Should Consider This Test
This specialized diagnostic panel is recommended for patients presenting with:
- Suspected germ cell tumors based on imaging studies
- Unexplained testicular or ovarian masses
- Elevated tumor markers such as AFP or beta-HCG
- Metastatic cancer of unknown primary origin
- Previous inconclusive biopsy results requiring further characterization
- Monitoring treatment response in known germ cell malignancies
Key Benefits of Immunohistochemistry Testing
- Precise Tumor Classification: Accurately identifies specific germ cell tumor subtypes
- Treatment Guidance: Helps oncologists select the most effective therapeutic approaches
- Prognostic Information: Provides insights into tumor behavior and potential outcomes
- Comprehensive Analysis: Multiple biomarker assessment ensures thorough evaluation
- Expert Interpretation: Results analyzed by experienced pathologists specializing in oncology
Understanding Your Test Results
Your immunohistochemistry results will provide detailed information about the expression patterns of each biomarker tested. Positive staining for specific markers helps classify the tumor into precise categories such as seminoma, embryonal carcinoma, yolk sac tumor, or choriocarcinoma. The combination of marker expressions allows our pathologists to provide a comprehensive diagnosis that guides your treatment team in developing the most appropriate management strategy. Normal results typically show absence of these specific tumor markers, while positive results indicate the presence of germ cell tumor elements requiring specialized oncological care.
Test Pricing and Availability
| Price Type | Amount (USD) |
|---|---|
| Discount Price | $146 |
| Regular Price | $162 |
Nationwide Accessibility
We maintain comprehensive testing facilities across the United States, with branches in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our centralized processing ensures consistent quality and rapid turnaround times regardless of your location.
Sample Requirements and Processing
Turnaround Time:
- Sample Collection: Daily by 6 PM
- Standard Tissue Biopsy: 5 days
- Tissue Block: 5 days
- Large Complex Tissue: 7 days
Sample Type: Submit tumor tissue in 10% formal-saline OR formalin fixed paraffin embedded block. Ship at room temperature.
Pre-test Instructions: Provide a copy of the Histopathology report, Site of biopsy and Clinical history.
Take Control of Your Health Today
Don’t let uncertainty about your diagnosis delay your treatment. Our Immunohistochemistry Germ Cell Tumor Panel Test provides the clarity and precision needed for effective cancer management. With our discounted price of $146 USD and comprehensive nationwide coverage, advanced diagnostic testing is more accessible than ever.
Call +1(267) 388-9828 now to schedule your test or speak with our oncology specialists about your diagnostic needs. Early and accurate diagnosis is the first step toward successful treatment outcomes.
